retatrutide illegal Demand for Unapproved Weight-Loss Drug Surges on Social Media June 8, 2026: Reckless physicians
Description
Gopal Grandhige, MD, FACS, Board-Certified Surgeon Last Reviewed: April 3, 2026 Retatrutide is an investigational triple-agonist weight-loss medication that activates three hormone receptors at once: GLP-1, GIP, and glucagon
Claim CME for this episode HERE
Adda et al
pH stability and activity curves of pepsin with special reference to their clinical importance
Biweekly meetings with a personal dietitian will help keep you on track, along with weekly classes we offer to help you learn more about the Shapely approach to weight loss
